NICOLETTI, FERDINANDO
 Distribuzione geografica
Continente #
NA - Nord America 20.629
EU - Europa 8.738
AS - Asia 8.626
SA - Sud America 1.741
AF - Africa 1.117
Continente sconosciuto - Info sul continente non disponibili 608
OC - Oceania 24
Totale 41.483
Nazione #
US - Stati Uniti d'America 19.830
SG - Singapore 4.340
CN - Cina 2.419
RU - Federazione Russa 2.391
IT - Italia 1.836
BR - Brasile 1.429
IE - Irlanda 1.377
UA - Ucraina 1.252
VN - Vietnam 677
CA - Canada 580
CI - Costa d'Avorio 481
FR - Francia 463
DE - Germania 334
SE - Svezia 316
KR - Corea 209
GB - Regno Unito 208
NG - Nigeria 208
SN - Senegal 183
IN - India 169
BD - Bangladesh 166
MX - Messico 108
AR - Argentina 100
HK - Hong Kong 96
NL - Olanda 80
ZA - Sudafrica 78
PL - Polonia 72
IQ - Iraq 67
JP - Giappone 64
EC - Ecuador 60
UZ - Uzbekistan 58
ES - Italia 55
FI - Finlandia 54
TR - Turchia 51
KE - Kenya 47
CO - Colombia 43
AT - Austria 41
CH - Svizzera 39
PK - Pakistan 39
ID - Indonesia 38
EE - Estonia 37
VE - Venezuela 37
IR - Iran 35
BE - Belgio 30
BG - Bulgaria 30
MA - Marocco 24
PH - Filippine 23
TN - Tunisia 22
GR - Grecia 20
JM - Giamaica 20
MY - Malesia 20
AU - Australia 19
PY - Paraguay 19
CR - Costa Rica 18
CL - Cile 17
LT - Lituania 17
PE - Perù 17
SA - Arabia Saudita 17
TT - Trinidad e Tobago 16
AE - Emirati Arabi Uniti 15
EG - Egitto 15
EU - Europa 15
BJ - Benin 14
JO - Giordania 14
LB - Libano 14
RO - Romania 14
UY - Uruguay 14
HN - Honduras 13
NP - Nepal 13
IL - Israele 12
DZ - Algeria 11
GE - Georgia 10
PT - Portogallo 10
CZ - Repubblica Ceca 9
DO - Repubblica Dominicana 9
ET - Etiopia 9
HU - Ungheria 9
OM - Oman 8
AL - Albania 7
AZ - Azerbaigian 7
BH - Bahrain 7
KZ - Kazakistan 7
BA - Bosnia-Erzegovina 6
BB - Barbados 6
GT - Guatemala 6
TH - Thailandia 6
AO - Angola 5
BY - Bielorussia 5
KG - Kirghizistan 5
NI - Nicaragua 5
BF - Burkina Faso 4
BO - Bolivia 4
HR - Croazia 4
MD - Moldavia 4
MK - Macedonia 4
PS - Palestinian Territory 4
SV - El Salvador 4
CG - Congo 3
KH - Cambogia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
Totale 40.836
Città #
Dallas 4.803
Singapore 2.437
Santa Clara 1.831
Jacksonville 1.476
Dublin 1.375
Chandler 1.327
San Jose 1.265
Moscow 997
Ashburn 785
Boardman 653
Catania 579
Chicago 566
Council Bluffs 496
Abidjan 481
Lawrence 380
Cambridge 377
Andover 371
Hefei 370
Nanjing 367
Lauterbourg 355
Toronto 349
Beijing 342
Houston 332
Los Angeles 296
Des Moines 230
Ho Chi Minh City 225
Seoul 205
San Mateo 197
Dakar 183
New York 169
Civitanova Marche 166
Wilmington 151
Hanoi 145
São Paulo 141
Nanchang 131
Grafing 129
Abuja 128
The Dalles 106
Columbus 104
Hebei 98
Saint Petersburg 94
Buffalo 91
Ottawa 81
Jiaxing 80
Hong Kong 77
Shenyang 77
Palermo 70
Brooklyn 68
Tianjin 67
Lagos 65
Changsha 61
Rome 61
Montreal 59
Orem 57
Tokyo 57
Amsterdam 53
Johannesburg 52
Phoenix 51
Bremen 48
Atlanta 47
Dong Ket 46
Warsaw 45
London 44
Milan 44
San Francisco 44
Seattle 44
Boston 41
Denver 40
Rio de Janeiro 39
Guangzhou 37
Lappeenranta 37
Belo Horizonte 35
Stockholm 34
Falls Church 33
Munich 31
Washington 31
Da Nang 30
Baghdad 29
Brussels 29
Hangzhou 29
Messina 28
Norwalk 27
Jakarta 26
Chennai 25
Poplar 25
Pune 25
Tashkent 25
Brasília 24
Haiphong 24
Mexico City 23
Mumbai 23
Nizza di Sicilia 22
Quito 22
Campinas 21
Curitiba 21
Jinan 21
Augusta 20
Dhaka 20
Frankfurt am Main 20
Kunming 20
Totale 27.638
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 424
The role of macrophages in neuroinflammatory and neurodegenerative pathways of alzheimer’s disease, amyotrophic lateral sclerosis, and multiple sclerosis: Pathogenetic cellular effectors and potential therapeutic targets 286
Advances in targeting signal transduction pathways. 248
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 245
Differential modulation and prognostic values of immune-escape genes in uveal melanoma 245
Ageing: from inflammation to cancer. 222
KCNMA1 Expression is Downregulated in Colorectal Cancer via Epigenetic Mechanisms 222
A potent immunomodulatory compound, (S,R)-3-phenyl-4,5-dihydro-5-isoxasole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice 216
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling. 210
A dual mechanism of neuroprotection by transforming growth factor-β1 against β-amyloid neurotoxicity 206
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs 205
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy 202
Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease 202
Akt as a therapeutic target in cancer 198
(S,R)-3-Phenyl-4,5 dihydro-5-isoxazole acetic acid – nitric oxide and use thereof as anti-cancer and antiviral agent 193
16alpha-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs 190
5-androstenediol ameliorates pleurisy, septic shock, and experimental autoimmune encephalomyelitis in mice. 188
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity. 188
(S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid–Nitric Oxide (GIT-27NO) – New Dress for Nitric Oxide Mission 184
Gasotransmitters and the immune system: Mode of action and novel therapeutic targets 182
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. 181
Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine 180
Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis 177
Characterization of the pathophysiological role of CD47 in uveal melanoma 177
CD3+CD25+ cells, CD3+CD4+/CD3+CD8+ ratio, HLA alloantigen association and ICA in type 1 (insulin-dependent) diabetes 175
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 171
Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets? 171
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 168
Androstene Hormones as regulators of Inflammation: role of Regulatory T Cells 166
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 164
Exploratory analysis of iPSCS-derived neuronal cells as predictors of diagnosis and treatment of Alzheimer disease 164
Computational Analysis of Pathogenetic Pathways in Alzheimer's Disease and Prediction of Potential Therapeutic Drugs 162
Anti-inflammatory and immune regulatory properties of 5-androsten-3 beta,17 beta-diol (HE2100), and synthetic analogue HE3204 implications for treatment of autoimmune diseases 162
CORRELATION BETWEEN ISLET CELL ANTIBODIES AND ANTICYTOMEGALOVIRUS IGM AND IGG ANTIBODIES IN HEALTHY 1ST-DEGREE RELATIVES OF TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS 162
CD4+T-cell gene expression of healthy donors, HIV-1 and elite controllers: Immunological chaos 162
17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson's Disease 161
Anti-melanoma potential of nitric oxide modified form of HIV inhibitor-saquinavir; cell specific mode of drug action 159
Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-Releasing Molecule CORM-A1, in a murine model of Autoimmune Hepatitis 159
Cognitive decline in rheumatoid arthritis: Insight into the molecular pathogenetic mechanisms 159
Comprehensive Analysis of TSPAN32 Regulatory Networks and Their Role in Immune Cell Biology 157
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma 157
The H2S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide 157
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences 156
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 154
Impaired expression of tetraspanin 32 (TSPAN32) in memory T cells of patients with multiple sclerosis 154
Emerging Raf inhibitors 153
Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-gamma and TNF-alpha and enhancement of IL-10 153
Identification of novel targets for the diagnosis and treatment of liver fibrosis. 153
Comparative study of rapamycin and temsirolimus demonstrate superimposable anti-tumor potency on prostate cancer cells 152
Androsteneidiol ameliorates experimental autoimmune encephalomyelitis in mice and may limit relapses in patients with multiple sclerosis 152
Anticancer and differentiation properties of the nitric oxide derivative of lopinavir in human glioblastoma cells 152
Emerging therapeutic targets for the treatment of hepatic fibrosis 151
Induction of OAS gene family in HIV monocyte infected patients with high and low viral load. 151
ANTICYTOMEGALOVIRUS IGM AND IGG ANTIBODIES, ISLET CELL ANTIBODIES AND GAMMA-INTERFERON SERUM LEVELS IN NEWLY DIAGNOSED IDDM PATIENTS 151
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment 151
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets 151
A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies 149
Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma 149
Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus 148
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis 148
Erratic expression of DNA polymerases by beta-amyloid causes neuronal death 148
Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania 147
. Autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide is inhibited by soluble TNF receptor type 1 147
Increased rate of survial in streptococcus pneumoniae -infected rats treated with the new immunomodulator pitotimod 145
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis 145
β-amyloid-activated cell cycle in SH-SY5Y neuroblastoma cells: Correlation with the MAP kinase pathway 144
Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF 144
A randomised, double blind, placebo-controlled trial on the effect of Fusidin in patients with newly diagnosed Type 1 diabetes: the FUSIDM tria 143
Prevention of cyclophosphamide-induced diabetes in the NOD/WEHI mouse with deoxyspergualin 143
Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone 141
Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis 141
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt 140
Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures 140
Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis. 139
Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats 139
Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock 139
Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo 138
Modulation of heat shock proteins during macrophage differentiation. 138
Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo 138
Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of Punica granatum L 137
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer 137
Endotoxin-induced lethality in neonatal mice is counteracted by interleukin-10 (IL-10) and exacerbated by anti-IL-10 137
Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2 135
). NO-hybridized protease inhibitors as a new class of anticancer compounds. Saquinavir-NO as prototypical example?. 134
Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia 133
Vitamin D3: a helpful immuno-modulator 133
Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells 133
Chronic administration of UK-114, a multifunctional emerging protein, modulates the Th1/Th2 cytokine pattern and experimental autoimmune diseases 133
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats 132
Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas 130
Protection from Experimental Autoimmune Thyroiditis in CBA Mice with the Novel Immunosuppressant Deoxyspergualin 130
Exogenous type-1 cytokines modulate mercury-induced hyper-IgE in the rat 129
Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease 129
Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti-Tumour Potency on Prostate Cancer Cells 129
Activation of group III metabotropic glutamate receptors is neuroprotective in cortical cultures 128
Effects of Tumour Necrosis Factor-alpha on Human Sperm Motility and Apoptosis 128
Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells 128
mTOR as a multifunctional therapeutic target in HIV infection 126
Prophylaxis with the novel immunomodulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndrome 126
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 126
Totale 16.287
Categoria #
all - tutte 146.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.133


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.108 0 0 4 54 438 57 399 92 253 8 72 731
2022/20234.363 409 155 55 377 423 801 19 766 1.062 60 129 107
2023/20241.777 117 245 86 170 65 393 12 120 10 75 281 203
2024/20257.365 64 1.084 467 298 1.740 646 233 346 567 748 656 516
2025/202617.934 1.008 2.803 3.098 1.041 2.288 2.726 1.912 421 863 842 465 467
2026/20271.349 620 692 37 0 0 0 0 0 0 0 0 0
Totale 41.483